Esophageal cancer: How far should we screen?
The incidence of esophageal adenocarcinoma has increased more than five-fold over the past four decades in the U.S. While the rate of rise in incidence of esophageal cancer has slowed somewhat in recent years, this malignancy is still associated with a dismal prognosis. Barrett’s esophagus, the precursor lesion to esophageal cancer, is easily identifiable on routine upper endoscopy and can be monitored for the development of precancerous changes. We generally assume that by performing endoscopic surveillance in our Barrett’s patients, we can detect high-grade dysplasia and esophageal cancer at early stages when it is s...
Source: Kevin, M.D. - Medical Weblog - June 1, 2014 Category: Journals (General) Authors: Julian A. Abrams, MD Tags: Conditions Cancer GI Source Type: blogs
Fecal transplants taken up by American Hospital Association in letter to HHS about Medicare/Medicaid
Interesting discussion of Fecal Transplants is this letter from the American Hospital Association to HHS about Medicaid / Medicare: Marilyn Tavenner September 6, 2013 Page 1 of 33 September 6 ...
Key text is below:
"FECAL MICROBIOTA TRANSPLANTATION
Fecal microbiota transplantation (FMT), also known as fecal bacteriotherapy, or human probiotic
infusion, is a medical treatment for patients with Clostridium difficile (C. difficile) enteritis or
ulcerative colitis. C. difficile infection occurs in patients who have been administered antibiotics
for a long period of time. The antibiotics ...
Source: The Tree of Life - September 7, 2013 Category: Medical Scientists Authors: Jonathan Eisen Source Type: blogs
